Core Viewpoint - The first Import Expo Quality Products Trade Fair in Shanghai showcased over 700 companies from more than 60 countries, emphasizing the importance of quality products and consumer engagement in the post-Expo period [3][10]. Group 1: Event Overview - The trade fair took place from December 19 to 21 at the National Exhibition and Convention Center in Shanghai, serving as a key extension of the Import Expo [3]. - The event featured a variety of products, including health foods from Oceania, home appliances from Europe, personal care items from the Americas, and beauty products from Asia, all popular among consumers [5]. Group 2: Innovative Sales Approach - New Zealand's New Zealand Dairy Company transformed its booth into an immersive 360-degree live streaming space, allowing for real-time interaction and purchases, effectively merging online and offline sales [9][10]. - The company's star product, colostrum milk powder, sold out its initial batch of 25,000 cans within a month of its global debut at the previous Import Expo, highlighting its popularity [9][10]. Group 3: Consumer Engagement and Education - The trade fair served as a platform for companies to educate consumers about their products, with Medtronic showcasing advanced medical technologies aimed at enhancing health consumer choices [14]. - The event included a special area for health education, where innovative medical products were displayed, emphasizing the importance of consumer awareness in health technology [16]. Group 4: Brand Participation and Market Impact - Companies like Sanofi and Boston Scientific presented products that had previously debuted at the Import Expo, demonstrating a successful transition from exhibition to market availability [15][16]. - Shiseido adopted a direct sales model at the trade fair, allowing consumers to experience products firsthand and make immediate purchases, reflecting a shift towards consumer-centric marketing strategies [17][18].

Core Insights - The Percept™ RC, the world's first rechargeable and sensing closed-loop brain stimulator, has commenced clinical applications in major hospitals across Beijing, Anhui, and Shanxi as of November 2025 [1][4] - Developed by Medtronic, the device integrates artificial intelligence and brain-machine interface technology, and is approved by the Chinese National Medical Products Administration, the US FDA, and the EU CE for treating complex neurological disorders such as Parkinson's disease and drug-resistant epilepsy [3][4] - The device has been recognized as one of TIME magazine's "Best Inventions of 2025" and has been featured prominently at the China International Import Expo [3][4] Clinical Application - The clinical application of Percept™ RC marks a significant breakthrough in brain stimulator therapy, advancing the use of brain-machine interface technology for treating neurological diseases in China [4] - The device offers a more intelligent, precise, and comfortable treatment option for patients, enhancing the overall treatment experience [4][8] Technological Advancements - Compared to traditional brain stimulators, Percept™ RC provides real-time sensing and analysis of brain activity, allowing for personalized and precise treatment tailored to the patient's condition [8] - It is the smallest and lightest brain stimulator globally, being 37% smaller than traditional models, which improves patient comfort [8] - The device features an open lifespan battery technology and is fully compatible with 3.0T and 1.5T MRI scans, ensuring patient safety and access to future medical imaging [8] Historical Context - Deep brain stimulation (DBS), commonly known as "brain pacemaker," has been recognized as the preferred surgical treatment for Parkinson's disease since its first successful operation in 1987 [5] - The therapy has been clinically applied for over 35 years globally, with its introduction to China occurring in 1999 [5]